ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Biological synthesis of gold nanoparticles using endophytic fungus Cladosporium sphaerospermum (RUV07) extract: characterization and in vitro antiproliferative effect of A549 cells.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this groundbreaking research, we utilized the fungal extract of Cladosporium sphaerospermum -RVU07 as a powerful reducing agent to create bioactive gold nanoparticles (Au-NPs). The comprehensive material characterization of the Au-NPs was conducted using methods including XRD, SEM, TEM, UV-vis, and DLS analysis. Notably, the successful formation of Au-NPs was confirmed by a striking color change of the precursor from pale yellow to vibrant violet. This transformation underscores the pivotal role of fungal bioactive molecules, which impart distinctive physicochemical and biological properties to the Au-NPs. The extraction of these compounds significantly influenced both the particle size and surface morphology, enhancing their effectiveness. We investigated the antiproliferative effect of the bioactive Au-NPs against lung cancer cells specifically A549. Our findings revealed that these nanoparticles and bioactive molecules effectively induce ROS production and drive nuclear damage-mediated cell death. With their nanoscale dimensions, the Au-NPs rapidly penetrate the atomic region of A549 cancer cells, facilitating substantial cellular dysfunction. Our nuclear damage assays confirmed that the Au-NPs lead to pronounced nuclear fragmentation and shrinkage in A549 cells following treatment. Additionally, we evaluated the biocompatibility of the Au-NPs against PBMC cells. The biosafety assay results convincingly showed that the bioactive molecules on the Au-NPs' surface significantly mitigate their toxic effects on normal cells. This research highlights the immense potential of mycosynthesized bioactive Au-NPs as innovative pharmaceuticals for a wide array of cancer therapies and biomedical applications, heralding a new era in targeted treatment solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.